Ophthalmic Drugs Used in Retinal Disorders
Retinal disorders are among the leading causes of vision impairment worldwide. Ophthalmic drugs designed for retinal diseases aim to control inflammation, abnormal blood vessel growth, and fluid accumulation in the retina.
Conditions such as age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion often require injectable ophthalmic drugs administered directly into the eye. These medications provide high local concentrations and target disease mechanisms effectively.
Anti-inflammatory and anti-angiogenic drugs are commonly used to reduce retinal swelling and prevent further damage. Treatment often requires repeated injections over time, guided by regular imaging and visual assessments.
Advances in retinal drug therapy have significantly improved outcomes, helping patients maintain functional vision and independence. Close monitoring ensures safety and treatment effectiveness.